PRISM
Protocol Risk Intelligence
Welcome, Dr. Sarah Mitchell
PRISM supports risk-based clinical trial oversight by systematically evaluating clinical trial protocols against an institutional knowledge base of validated historical protocol deviations, quality signals, and risk patterns. Lab Manuals and Pharmacy Manuals may be included as supporting documents to enhance contextual risk evaluation.
The system identifies potential risks and proposes corresponding mitigation recommendations to support proactive risk management, data integrity, and regulatory compliance.
All analyses are performed using controlled, versioned inputs to ensure traceability, reproducibility, and alignment with GxP and 21 CFR Part 11 requirements.
Get Started: Upload your clinical trial protocol and optional supporting documents on the next page to initiate a controlled risk assessment.
Ready to begin?
Intended Use & Limitations
PRISM is intended to support risk-based quality management (RBQM) by providing decision-support insights for identifying potential clinical trial risks and recommended mitigations.
Decision support
Provides insights to support RBQM review and prioritization.
Human confirmation
Outputs require review and confirmation by qualified personnel.
No autonomous decisions
The system does not autonomously approve, reject, or enforce risk decisions.